Home > Drug Search >
  • company_query: Ascenta
  •   > 
Drug Filter
Category:
chemistry (33) biology (6)
Status:
Approved (1) Phase Ⅲ (3) Phase Ⅱ (17) Phase Ⅰ (18)
Clinical Stage:
Pending (6) Active (28) Discontinued (4)
Bio-Type:
Vaccine (1) Recombinant enzyme (1) Whole antibody (2)
Indication:
Acute coronary syndrome (ACS) (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Asthma (1) Atopic dermatitis (1) Chronic lymphocytic leukemia (CLL) (1) Crohn's disease (2) Cystic fibrosis (CF) (2) Diabetic neuropathic pain (DNP) (1) Duchenne muscular dystrophy (DMD) (1) Gastric cancer (3) Glaucoma (1) Glioblastoma multiforme (1) HCV infection (2) Huntington's disease (1) Hypertension (1) Idiopathic pulmonary fibrosis (IPF) (1) Inflammatory bowel disease (1) Leukemia (3) Lymphoma (2) Multiple myeloma (MM) (2) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (2) Non-alcoholic fatty liver disease (NAFLD) (1) Ocular hypertension (1) Osteoarthritis (OA) (1) Overactive bladder (OAB) (1) Postmenopausal osteoporosis (2) Prader-Willi syndrome (1) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (3) Small cell lung cancer (SCLC) (1) Solid tumours (4) Type 2 diabetes (1) Ulcerative colitis (1) Head and neck cancer (1) Ankylosing Spondylitis (AS) (1) Myeloproliferative Disorders (MPD) (1) Systemic bacterial infections (1) B-cell lymphoma (1) Contraception (1) Hematological cancer (1) Gallstone (1) Metastatic cancer (1) Thrombosis (1) Stem cell mobilization (1) Lipodystrophy (1) Liver cancer (2) hematological malignancies (1) Inflammation (1) Cachexia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top